# 18F-Pentixafor PET in Hematologic Malignancies

> **NCT07122674** · — · RECRUITING · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 100 (estimated)

## Conditions studied

- Hematological Malignancies

## Interventions

- **DRUG:** 18F-Pentixafor

## Key facts

- **NCT ID:** NCT07122674
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2028-12
- **Final completion:** 2029-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07122674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07122674, "18F-Pentixafor PET in Hematologic Malignancies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07122674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*